Design of an innovative nanovehicle to enhance brain permeability of a novel 5-HT6 receptor antagonist
dc.contributor.author | Alvarez-Figueroa, Maria Javiera | |
dc.contributor.author | Nunez-Navarro, Francisco | |
dc.contributor.author | Recabarren-Gajardo, Gonzalo | |
dc.contributor.author | Gonzalez-Aramundiz, Jose Vicente | |
dc.date.accessioned | 2025-01-20T16:04:36Z | |
dc.date.available | 2025-01-20T16:04:36Z | |
dc.date.issued | 2024 | |
dc.description.abstract | An innovative nanovehicle based on lipid nanocapsules (LNC) was designed to facilitate the passage of a new 5HT6 receptor antagonist, namely PUC-10, through the blood-brain barrier. PUC-10 is a new synthetic N-arylsulfonylindole that has demonstrated potent 5-HT6 receptor antagonist activity, but it exhibits poor solubility in water, which indicates limited absorption. The lipid nanocapsules designed had a nanometric size (53 nm), a monomodal distribution (PI<0.2), a negative Z potential (-17 +/- 7 mV) and allowed efficient PUC-10 encapsulation (74 %). Furthermore, the LNC demonstrated to be stable for at least 4 weeks at 4( degrees)C (storage conditions), for at least 4 h in DMEM at pH 7.4, and for 18 h in water with 5 % DMSO, with both latter conditions maintained at 37 C-degrees. They also demonstrated that cell viability was not affected at the different concentrations studied. Finally, in vitro studies that simulate the blood brain barrier (PAMPA-BBB) demonstrated that the nanoencapsulation of PUC-10 promoted their penetration through the blood-brain barrier, with a calculated permeability of 1.3 x 10(- 8 )cm/s, compared to the null permeability exhibited by non-nanoencapsulated PUC-10. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1016/j.ijpx.2024.100296 | |
dc.identifier.eissn | 2590-1567 | |
dc.identifier.uri | https://doi.org/10.1016/j.ijpx.2024.100296 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/89813 | |
dc.identifier.wosid | WOS:001349297000001 | |
dc.language.iso | en | |
dc.revista | International journal of pharmaceutics-x | |
dc.rights | acceso restringido | |
dc.subject | Lipid nanocapsules | |
dc.subject | PAMPA-BBB | |
dc.subject | Brain permeability | |
dc.subject | Arylsulfonylindoles | |
dc.subject | 5-HT6 receptor | |
dc.title | Design of an innovative nanovehicle to enhance brain permeability of a novel 5-HT6 receptor antagonist | |
dc.type | artículo | |
dc.volumen | 8 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |